Effects of nifedipine and enalapril on cardiac autonomic nervous function during the tilt test in elderly patients with hypertension

Hypertension Research

Volumn 20, Issue 1, 1997, Pages 1-6

  Okabayashi, Junko ^a   Matsubayashi, Kozo ^a   Doi, Yoshinori ^a   Sato, Takayuki ^b   Ozawa, Toshio ^c  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Cardiac autonomic nervous function; Elderly patients with hypertension; Enalapril; Nifedipine; Power spectral analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; NIFEDIPINE; NORADRENALIN;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FUNCTION TEST; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; POWER SPECTRUM; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VARIANCE;

EID: 0030890328     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.1     Document Type: Article

References (24)

1. Lipsitz LA: Orthostatic hypotension in the elderly. N Engl J Med 1989; 321: 952-957.
2. Masuo K, Mikami H, Ogihara T: The frequency of orthostatic hypotension in elderly patients with essential hypertension, isolated systolic hypertension and borderline hypertension. J Hypertens 1993; 11 (Suppl 5): 306-307.
3. Davis BR, Langford HG, Blaufox MD, et al: The association of postural changes in systolic blood pressure and mortality in persons with hypertension: the hypertension detection and follow-up program experience. Circulation 1987; 75: 340-346.
4. Imataka K, Sakamoto H, Nishimura H, Ieki K, Fujii J: Trends in antihypertensive drugs used for elderly patients. Jpn J Geriatr 1992; 29: 503-508.
5. Psaty BM, Savage PJ, Tell GS, et al: Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA 1993; 270: 1837-1841.
6. Pagani M, Lombardi F, Guzzetti S, et al: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-193.
7. Yamasaki F, Sato T, Dol Y, et al: Diurnal change of autonomic nervous system in vasospastic angina: a study using power spectral analysis. J Cardiol 1994; 24 (Suppl 41): 63-65.
8. Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H: Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 1993; 21: 866-874.
9. Akaike, H: Fitting autoregressive models for prediction. Ann Stat Math 1969; 21: 243-247.
10. Sato K, Ono K, Chiba G, Fukata K: Component activities in the autoregressive activity of physiological systems, Int J Neurosci 1977; 7: 239-249.
11. Hayano J, Sakakibara Y, Yamada A, et al: Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991; 67: 199-204.
12. Kozakai K, Tanaka N, Abe K, et al: Determination of serum aldosterone by SPAC-S aldosterone kit. School Med 1990; 23: 325-330.
13. Shimada K, Kitazumi T, Sadakane M, Ogura H, Ozawa T: Age-related changes of baroreflex function, plasma norepinephrine, and blood pressure. Hypertension 1985; 7: 113-117.
14. Bertel O, Bühler FR, Kiowski W, Lütold BE: Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 1980; 2: 130-138.
15. Okabayashi J, Matsubayashi K, Sato T, Ozawa T: Effects of nifedipine and enalapril on cardiac autonomic activity in elderly hypertensive patients. Jpn J Geriatr 1994; 31: 285-292.
16. Corea L, Miele N, Bentvoglio M, et al: Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients. Clin Sci 1979; 57: 115-117.
17. Schwietzer G, Distler A, Reeck S, Thiede HM, Philipp T: Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline. J Hypertens 1983; 1 (Suppl 2): 102-104.
18. Vierhapper H, Waldhaüsl W: Reduced pressor effect of angiotensin II and of noradrenaline in normal man following the oral administration of the calcium-antagonist nifedipine. EurJ Clin Med 1982; 12: 263-267.
19. The Israeli Sprint Study Group: Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988; 9: 354-364.
20. Held PH, Yusuf S, Furberg CD: Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989; 299: 1187-1192.
21. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
22. Kaufman ES, Bosner MS, Bigger JT, et al: Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects. Am J Cardiol 1993; 72: 95-99.
23. Veerman DP, Douma CE, Jacobs MC, Thien T, Van Montfrans GA: Effects of ACE inhibition on autonomic vascular control, as assessed by spectral analysis, and on haemodynamics. Blood Press Suppl 1994; 2: 92.
24. Cerasola G, Cottone S, D'Ignoto G, et al: Effects of enalapril maleate on blood pressure, reninangiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Clin Ther 1987; 9: 390.